Cardiac POC Testing Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers POC Testing Devices Market Trends and the market is segmented by Product Type (Cardiac Markers Test and Analyzers), End User (Hospitals, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Cardiac POC Testing Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cardiac PoC Testing Devices Market Size

Cardiac PoC Testing Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Cardiac PoC Testing Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cardiac PoC Testing Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cardiac PoC Testing Devices Market Analysis

The Cardiac PoC Testing Devices Market is expected to register a CAGR of 6.5% during the forecast period.

The COVID-19 pandemic significantly impacted market growth. The onset of the COVID-19 pandemic caused a nationwide lockdown with the suspension of non-urgent scheduled visits and hospitalizations, which resulted in the delayed diagnosis of patients with cardiac disorders. For instance, according to an article published in Elsevier Public Health Emergency Collection in September 2021, it was observed that the reduction in diagnostic cardiovascular testing around the world led to concerns about the effects of reduced testing for cardiovascular disease (CVD) morbidity and mortality. In addition, as per the same source, the number of procedures decreased differently in each US region, the Northeast (76%) and Midwest (74%) experienced greater declines than the South (62%) and West (44%), impacting the market growth during the pandemic. However, the rising cardiac complications among patients, especially after contracting the coronavirus, increased the demand and need for cardiac POC testing devices to prevent cardiac complications. Currently, the market is expected to have stable growth during the forecast period.

Factors such as the rising incidence and prevalence of cardiovascular diseases and technological advances in cardiac POC testing devices are boosting market growth. For instance, according to the British Heart Foundation England Factsheet, published in January 2022, about 6.4 million people were living with cardiovascular diseases in England in 2021. In addition, according to the March 2022 update of the Australian Bureau of Statistics, the prevalence of heart disease in Australia was 4.0%, about 1 million people, in 2020-21. Also, as per the same source, in Australia, heart disease increased with age, from 2.3% of people aged 45-54 years through to 23.2% of people aged 75 years and over, with males being the most affected by it in the country. Thus, the high burden of CVD among the population increases the need for early detection of the condition, which in turn is anticipated to fuel the demand for cardiac POC testing devices over the forecast period.

Furthermore, according to an article published in Minerva Cardiology and Angiology, in June 2021, it was observed that the age-standardized estimates of CVD prevalence in Italy were similar, but the country's crude prevalence of CVD is almost two times higher than the global prevalence (12.9% vs. 6.6%). Thus, the increasing prevalence of heart diseases raises the need for cardiac POC testing devices for detecting cardiac disorders such as myocardial infarction, heart failure, and coronary syndromes, which help in delivering care based on the results of the POC tests. This is anticipated to fuel the market growth over the forecast period.

Moreover, rising product launches by the market players are expected to drive this market's growth further. For instance, in January 2022, PocDoc, a digital health platform and personal diagnostics provider, launched the world-first smartphone-based test for cardiovascular disease. The PocDoc test encompasses the entire five-marker lipid panel, which has been recognized as the global standard for evaluating cardiovascular health. Also, in July 2021, Beckman Coulter Inc. entered into definitive agreements with Quidel Corporation to acquire all rights related to the manufacture, distribution, and sale of the BNP test for Beckman Coulter analyzers. Under the terms of the agreement, Quidel will continue to manufacture and supply certain test-related components to Beckman Coulter, and it will exclusively manufacture the BNP test.

Therefore, owing to the factors such as the growing burden of cardiovascular diseases and rising technological advancement and product launches, the studied market is expected to grow over the forecast period. However, the lack of operating knowledge among the workforce and stringent regulations in the industry are likely to impede the growth of the cardiac POC testing devices market over the forecast period.

Cardiac PoC Testing Devices Industry Overview

The cardiac POC testing devices market is competitive in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold the market shares and are well known, including Abbott Laboratories, ACON Laboratories Inc., Alfa Scientific Designs Inc., American Screening Corporation Inc., Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Nano-Ditech Corporation, Nova Biomedical Corporation, and Siemens Healthineers AG.

Cardiac PoC Testing Devices Market Leaders

  1. Abbott Laboratories

  2. ACON Laboratories, Inc.

  3. Beckman Coulter Inc. (Danaher Corporation)

  4. Siemens Healthineers AG

  5. Bio-Rad Laboratories, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Cardiac PoC Testing Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cardiac PoC Testing Devices Market News

  • Mar 2022: Mylab Discovery Solutions launched an entire range of routine diagnostic kits and devices in a conventional and point-of-care format that includes the devices and kits for Immunology, Biochemistry, and Haematology. With this launch, the company helps the laboratories to use its devices and reagent kits to do all routine tests such as liver panels, cardiac profiles, urine panels, hormone panels, and other tests.
  • Jan 2022: MEDLAB Middle East, Abbott (Lake Forest, IL, USA), showcased its portfolio of life-changing diagnostic tools and medical devices for point-of-care testing that help manage patients with COVID-19, diabetes, cardiovascular disease, and comorbidities.

Cardiac PoC Testing Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence and Prevalence of Cardiovascular Disease
    • 4.2.2 Technological Advances in Cardiac POC Testing Device
  • 4.3 Market Restraints
    • 4.3.1 Lack of Operating Knowledge among Workforce
    • 4.3.2 Stringent Regulations in the Industry
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Cardiac Markers Test
    • 5.1.1.1 Cardiac Troponin (cTn) Test
    • 5.1.1.2 Myoglobin Test
    • 5.1.1.3 Creatine Kinase MB Isoenzyme (CK-MB) Test
    • 5.1.1.4 Combinational Test Kits
    • 5.1.1.5 Brain Natriuretic Peptide (BNP) Test
    • 5.1.2 Analyzers
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Laboratories
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 ACON Laboratories Inc.
    • 6.1.3 Alfa Scientific Designs Inc.
    • 6.1.4 American Screening Corporation Inc.
    • 6.1.5 Beckman Coulter Inc. (Danaher Corporation)
    • 6.1.6 Bio-Rad Laboratories Inc.
    • 6.1.7 F. Hoffmann-La Roche Ltd
    • 6.1.8 Nano-Ditech Corporation
    • 6.1.9 Nova Biomedical Corporation
    • 6.1.10 Siemens Healthineers AG
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cardiac PoC Testing Devices Industry Segmentation

As per the scope of the report, cardiac POC testing is a heart-related diagnostic test that is performed at or near a patient's point of care. Cardiac POC testing devices are frequently used to diagnose cardiac disorders such as myocardial infarction, heart failure, and coronary syndromes. These devices can detect enzymes, including brain natriuretic peptides, kinase, synthesizing troponin, and lactate dehydrogenase isoenzymes that are generated during heart failure and other critical cardiac situations. The Cardiac PoC Testing Devices Market is Segmented by Product Type (Cardiac Markers Test and Analyzers), End User (Hospitals, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the market size and forecasts in value (USD million) for the above segments.

By Product Type Cardiac Markers Test Cardiac Troponin (cTn) Test
Myoglobin Test
Creatine Kinase MB Isoenzyme (CK-MB) Test
Combinational Test Kits
Brain Natriuretic Peptide (BNP) Test
Analyzers
By End User Hospitals
Diagnostic Laboratories
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cardiac PoC Testing Devices Market Research FAQs

What is the current Cardiac PoC Testing Devices Market size?

The Cardiac PoC Testing Devices Market is projected to register a CAGR of 6.5% during the forecast period (2025-2030)

Who are the key players in Cardiac PoC Testing Devices Market?

Abbott Laboratories, ACON Laboratories, Inc., Beckman Coulter Inc. (Danaher Corporation), Siemens Healthineers AG and Bio-Rad Laboratories, Inc. are the major companies operating in the Cardiac PoC Testing Devices Market.

Which is the fastest growing region in Cardiac PoC Testing Devices Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cardiac PoC Testing Devices Market?

In 2025, the North America accounts for the largest market share in Cardiac PoC Testing Devices Market.

What years does this Cardiac PoC Testing Devices Market cover?

The report covers the Cardiac PoC Testing Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Cardiac PoC Testing Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cardiac POC Testing Industry Report

Statistics for the 2025 Cardiac PoC Testing Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cardiac PoC Testing Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.